Evidence map›Paper›PMID 29887481›Full record

Observational studyInternational journal of cardiology2018

New-onset atrial fibrillation in critically ill patients and its association with mortality: A report from the FROG-ICU study.

Mattia Arrigo, Shiro Ishihara, Elodie Feliot, Alain Rudiger, Nicolas Deye, Alain Cariou, Bertrand Guidet, Samir Jaber, Marc Leone, Matthieu Resche-Rigon and 4 more

Open access · greenAbstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in International journal of cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Mattia ArrigoDepartment of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France; Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland. Electronic address: mattia.arrigo@usz.ch.
Shiro IshiharaDepartment of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France.
Elodie FeliotDepartment of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France.
Alain RudigerCardiosurgical Intensive Care Unit, Institute of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland. Electronic address: alain.rudiger@usz.ch.
Nicolas DeyeDepartment of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France. Electronic address: nicolas.deye@aphp.fr.
Alain CariouMedical Intensive Care Unit, AP-HP, Hôpital Cochin, Paris, France. Electronic address: alain.cariou@aphp.fr.
Bertrand GuidetMedical Intensive Care Unit, AP-HP, Hôpital Saint-Antoine and INSERM UMR-S 1136, Paris, France. Electronic address: betrand.guidet@aphp.fr.
Samir JaberDepartment of Anaesthesiology and Critical Care Medicine, Saint-Eloi University Hospital, Montpellier, France. Electronic address: s-jaber@chu-montpellier.fr.
Marc LeoneDepartment of Anaesthesiology and Critical Care Medicine, AP-HM, Hôpital Nord, Marseille, France. Electronic address: marc.leone@ap-hm.fr.
Matthieu Resche-RigonSBIM, Biostatistics and Clinical Epidemiology Research Unit Department, AP-HP, Saint Louis University Hospital, Paris, France. Electronic address: matthieu.resche-rigon@univ-paris-diderot.fr.
Antoine Vieillard BaronDepartment of Anesthesiology and Critical Care Medicine, AP-HP, Hôpital Ambroise Paré, Paris, France. Electronic address: antoine.vieillard-baron@aphp.fr.
Matthieu LegrandDepartment of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France. Electronic address: matthieu.legrand@aphp.fr.
Etienne GayatDepartment of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France. Electronic address: etienne.gayat@aphp.fr.
Alexandre MebazaaDepartment of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals and INSERM UMR-S 942, Paris, France. Electronic address: alexandre.mebazaa@aphp.fr.
Inserm · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Montpellier · FRDélégation Paris 7 · FRHôpital Cochin · FRHôpital Nord · FRUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAtrial fibrillation (AFib) is associated with adverse outcome in critical illness, but whether this effect is independent from other risk factors remains uncertain. New-onset AFib during critical illness may be independently associated with increased in-hospital and long-term risk of death.

methodsFROG-ICU was a prospective, observational, multi-centre cohort study designed to investigate the outcome of critically ill patients. Inclusion criteria were invasive mechanical ventilation and/or treatment with a positive inotropic agent for >24 h. Heart rhythm was assessed at inclusion and during ICU stay with digital ECG recordings. Among patients who had AFib during ICU stay, new-onset and recurrent AFib were diagnosed in patients without and with previous history of AFib, respectively. Primary endpoint was in-hospital mortality; secondary endpoint was 1-year mortality among ICU survivors.

resultsThe study included 1841 critically ill patients. During ICU stay, AFib occurred in 343 patients (19%). New-onset AFib (n = 212) had higher in-hospital mortality compared to no AFib (47 vs. 23%, P < 0.001) or recurrent AFib (34%, P = 0.032). New-onset AFib showed increased risk of in-hospital death after multivariable adjustment compared to no AFib (OR 1.6, P = 0.003) or recurrent AFib (OR 1.8, P = 0.02). Among the 1464 ICU-survivors, new-onset AFib during ICU stay showed higher post-ICU risk of death compared to no AFib (HR 2.2, P < 0.001). After multivariable adjustment, new-onset AFib showed higher post-ICU risk of death compared to no AFib (HR 1.6, P = 0.03).

conclusionNew-onset AFib is independently associated with in-hospital and post-ICU risk of death in critically ill patients.

Indexed as

Atrial FibrillationCohort StudiesCritical IllnessFemaleFranceHospital MortalityHumansIntensive Care UnitsMaleProspective StudiesResearch ReportAtrial fibrillationCritical illnessICUMortalityOutcome

Identifiers

PMID29887481
OpenAlexW2807486090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.